Genomic sequencing recommended earlier in evaluation of developmental delay, with Christine Eng, MD
Christine Eng, MD, Chief Medical Officer and Chief Quality Officer, explains how exome and genome sequencing are now being used as first-line diagnostic tools to evaluate children with developmental delay and intellectual disability, helping clinicians move quickly from testing to informed care and management decisions.
Watch the full video on the Contemporary Pediatrics website.
About Baylor Genetics
Baylor Genetics is a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, from clinical-grade genomic sequencing to expert interpretation, including Whole Genome Sequencing, Whole Exome Sequencing, and focused panels. Baylor Genetics combines rapid and comprehensive precision diagnostics options with the support of genetic counselors to help clinicians avoid a lengthy diagnostic odyssey for their patients, guide medical management, and ensure no patient with a genetic disorder gets left behind. Baylor Genetics’ testing menu covers family planning, pregnancy, neonatal and pediatric testing, oncology, pharmacogenomics and many other specialized testing options. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states.